APA (7th ed.) Citation

A, A., A, P., D, R., R, C., R, M., Á, M., . . . M, Z. (2022). Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19. Frontiers in immunology, 13, 881604. https://doi.org/10.3389/fimmu.2022.881604

Chicago Style (17th ed.) Citation

A, Agurto-Arteaga, et al. "Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19." Frontiers in Immunology 13 (2022): 881604. https://doi.org/10.3389/fimmu.2022.881604.

MLA (9th ed.) Citation

A, Agurto-Arteaga, et al. "Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19." Frontiers in Immunology, vol. 13, 2022, p. 881604, https://doi.org/10.3389/fimmu.2022.881604.